,
A British multinational generics and in licensed pharmaceutical company approached Freyr to perform challenging NDA review-based medical writing operations to be submitted to USFDA.
The client was facing stringent timelines challenges to complete this project. With our medical experts deep review and understanding the submission was made in a timely manner with the necessary details required by the Health Agency.
Download the proven case now.
Fill the form below to download the Case Study
